We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Regeneron Pharmaceuticals Inc | NASDAQ:REGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
12.82 | 1.44% | 903.48 | 906.00 | 915.00 | 913.21 | 888.73 | 889.41 | 595,183 | 00:44:45 |
New York
|
000-19034
|
13-3444607
|
|
(State or other jurisdiction of incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
777 Old Saw Mill River Road
|
Tarrytown,
|
New York
|
10591-6707
|
(Address of Principal Executive Offices, including zip code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock - par value $.001 per share
|
REGN
|
NASDAQ Global Select Market
|
Date: February 6, 2020
|
|
REGENERON PHARMACEUTICALS, INC.
|
|
|
|
|
|
|
|
By:
|
/s/ Joseph J. LaRosa
|
|
|
Name:
|
Joseph J. LaRosa
|
|
|
Title:
|
Executive Vice President, General Counsel and Secretary
|
1 Year Regeneron Pharmaceuticals Chart |
1 Month Regeneron Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions